Stillpoint founder Eric Wong reveals major China tech investment strategy

Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14.
Stillpoint Investments founder and chief investment officer Eric Wong. Picture: Jaclyn Licht

David Rogers

Stillpoint founder Eric Wong reveals major China tech investment strategy

September 25, 2025
Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14.
Read Transcript

Eric Wong has seen plenty of market cycles. The founder of Stillpoint Investments cut his teeth during the global financial crisis, working for legendary hedge fund manager John Griffin at Blue Ridge Capital, himself a protégé of the great Julian Robertson of Tiger Management.

Now Wong is betting big on China. His Greater China equity fund is capitalising on what he sees as a once-in-a-decade opportunity as Chinese tech stocks surge from bargain valuation levels.

“China’s markets continue to trade at a meaningful discount to the S&P,” Wong says. “It’s trading at a PE ratio of 12 to 13 times, whereas the US is approaching the mid-20s. From a cash flow yield perspective, China’s trading at seven-plus per cent and the US is at slightly less than three per cent.”

“You almost are able to get a 50 per cent discount on the broader market.”

Wong spent 11 years at Blue Ridge Capital, where Griffin built a track record of 15.4 per cent annual returns over two decades. Griffin’s influence on Wong went beyond just investing.

“His influence on me has been holistic in so many different ways, beyond just investing — thinking about life and wellness and how that actually enhances how we think about the investment landscape,” Wong tells The Australian.

The experience shaped Wong’s approach at Stillpoint, which he founded in 2022.

Like his mentor, Wong is a generalist who goes where the opportunities are richest.

Currently, that’s artificial intelligence infrastructure in China. The numbers are staggering.

“What we’re seeing happening in China is the hyperscalers, like the ByteDances and the Alibabas, are actually expanding their AI infrastructure capital expenditure dramatically,” Wong says.

“This year, the broader capex is going up by 60 per cent year-on-year.”

These data centre companies are trading at just 12 to 13 times EBITDA, compared to their global peers at well above 20 times.

The geopolitical headlines around chip bans have also created opportunities.

“The news around the chip bans will create uncertainty from market perception in terms of how sustainable this growth is,” he says. “But, from our perspective, it’s more around the matter of which chips they use. They will still need the data centres.”

Wong’s second major theme is precision manufacturing. Companies operating in the space help expand manufacturing capacity outside China as supply chains reshape in an increasingly multipolar world.

“These are businesses that are actually helping expand manufacturing capacity in markets outside of China,” he says. “When you think about the reshaping of what manufacturing looks like in a more de-globalised world, these businesses are actually in a position to benefit during this geopolitical tension.”

These companies trade at single-digit price-to-earnings multiples and pay dividend yields of eight to nine per cent. His conviction comes from seeing China’s technological advancement first-hand during his frequent visits. While based in New York City, Wong spends about a third of his time in China.

The technology integration into daily life is remarkable. At hotels, robots deliver room service from ground-floor cabinets to guest rooms. Hotel TVs show real-time availability of washing machines so guests don’t waste trips to the laundry.

“I think what I’m trying to illustrate is that the ease of life that is brought by technology, even in the simplest ways, helps improve efficiency and lower inconvenience,” Wong says.

“These types of use cases from a consumer perspective are actually very present in day-to-day life.”

As evidence the long winter for Chinese equities may be ending, he notes southbound liquidity flowing into Hong Kong this year has already surpassed all of 2024. IPO activity has also picked up and margin trading is increasing sustainably.

Most tellingly, Chinese household deposits fell for two consecutive months recently, with money shifting into equity markets.

“I’ve always viewed that this closing of winter in Chinese equity markets needs to be led by the domestic investor,” Wong says. For global investors, Wong believes China simply can’t be ignored.

“It’s a market you can’t ignore — second largest economy in the world. It’s a place that I think every investor has to visit, at the very least. From an allocation perspective, what we’ve seen over recent years in terms of foreign capital fleeing, I think that’s certainly worth revisiting.”

Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14, 2025.

The annual conference features stock picks from leading global investment experts, with all profits donated to medical research.

This year marks 10 years of the conference, which has raised over $83.7m.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Eric Wong has seen plenty of market cycles. The founder of Stillpoint Investments cut his teeth during the global financial crisis, working for legendary hedge fund manager John Griffin at Blue Ridge Capital, himself a protégé of the great Julian Robertson of Tiger Management.

Now Wong is betting big on China. His Greater China equity fund is capitalising on what he sees as a once-in-a-decade opportunity as Chinese tech stocks surge from bargain valuation levels.

“China’s markets continue to trade at a meaningful discount to the S&P,” Wong says. “It’s trading at a PE ratio of 12 to 13 times, whereas the US is approaching the mid-20s. From a cash flow yield perspective, China’s trading at seven-plus per cent and the US is at slightly less than three per cent.”

“You almost are able to get a 50 per cent discount on the broader market.”

Wong spent 11 years at Blue Ridge Capital, where Griffin built a track record of 15.4 per cent annual returns over two decades. Griffin’s influence on Wong went beyond just investing.

“His influence on me has been holistic in so many different ways, beyond just investing — thinking about life and wellness and how that actually enhances how we think about the investment landscape,” Wong tells The Australian.

The experience shaped Wong’s approach at Stillpoint, which he founded in 2022.

Like his mentor, Wong is a generalist who goes where the opportunities are richest.

Currently, that’s artificial intelligence infrastructure in China. The numbers are staggering.

“What we’re seeing happening in China is the hyperscalers, like the ByteDances and the Alibabas, are actually expanding their AI infrastructure capital expenditure dramatically,” Wong says.

“This year, the broader capex is going up by 60 per cent year-on-year.”

These data centre companies are trading at just 12 to 13 times EBITDA, compared to their global peers at well above 20 times.

The geopolitical headlines around chip bans have also created opportunities.

“The news around the chip bans will create uncertainty from market perception in terms of how sustainable this growth is,” he says. “But, from our perspective, it’s more around the matter of which chips they use. They will still need the data centres.”

Wong’s second major theme is precision manufacturing. Companies operating in the space help expand manufacturing capacity outside China as supply chains reshape in an increasingly multipolar world.

“These are businesses that are actually helping expand manufacturing capacity in markets outside of China,” he says. “When you think about the reshaping of what manufacturing looks like in a more de-globalised world, these businesses are actually in a position to benefit during this geopolitical tension.”

These companies trade at single-digit price-to-earnings multiples and pay dividend yields of eight to nine per cent. His conviction comes from seeing China’s technological advancement first-hand during his frequent visits. While based in New York City, Wong spends about a third of his time in China.

The technology integration into daily life is remarkable. At hotels, robots deliver room service from ground-floor cabinets to guest rooms. Hotel TVs show real-time availability of washing machines so guests don’t waste trips to the laundry.

“I think what I’m trying to illustrate is that the ease of life that is brought by technology, even in the simplest ways, helps improve efficiency and lower inconvenience,” Wong says.

“These types of use cases from a consumer perspective are actually very present in day-to-day life.”

As evidence the long winter for Chinese equities may be ending, he notes southbound liquidity flowing into Hong Kong this year has already surpassed all of 2024. IPO activity has also picked up and margin trading is increasing sustainably.

Most tellingly, Chinese household deposits fell for two consecutive months recently, with money shifting into equity markets.

“I’ve always viewed that this closing of winter in Chinese equity markets needs to be led by the domestic investor,” Wong says. For global investors, Wong believes China simply can’t be ignored.

“It’s a market you can’t ignore — second largest economy in the world. It’s a place that I think every investor has to visit, at the very least. From an allocation perspective, what we’ve seen over recent years in terms of foreign capital fleeing, I think that’s certainly worth revisiting.”

Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14, 2025.

The annual conference features stock picks from leading global investment experts, with all profits donated to medical research.

This year marks 10 years of the conference, which has raised over $83.7m.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Sep 25, 2025. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Azora Capital founder Ravi Chopra. Picture: Renee NowytargerAzora Capital founder Ravi Chopra. Picture: Renee NowytargerAzora Capital founder Ravi Chopra. Picture: Renee NowytargerAzora Capital founder Ravi Chopra. Picture: Renee Nowytarger
November 17, 2023

Webster Financial ‘Avoided The Mistakes Of US Bank Failures’

The US financial sector is not without its problems but Ravi Chopra backs Webster Financial Corporation as his stock pick for the 2023 Sohn Hearts & Minds Investment Leaders Conference.

Read More
November 17, 2023

Why Stock Picker Cathie Wood Of ARK Can’t Stand Google

The world’s highest-profile tech investor, Cathie Wood, might be bruised but she is certainly bullish. Nor is she holding back.

Read More
Munro Partners partner and portfolio manager Kieran Moore at the Sohn Hearts & Minds conference in Sydney. Picture: Renee NowytargerMunro Partners partner and portfolio manager Kieran Moore at the Sohn Hearts & Minds conference in Sydney. Picture: Renee NowytargerMunro Partners partner and portfolio manager Kieran Moore at the Sohn Hearts & Minds conference in Sydney. Picture: Renee NowytargerMunro Partners partner and portfolio manager Kieran Moore at the Sohn Hearts & Minds conference in Sydney. Picture: Renee Nowytarger
November 17, 2023

Wise Share Price Could Rise 50pc By 2025, Says Munro Partners

Global growth fund manager Munro has about $4.3bn in funds under management across four global funds, and usually invests in companies that are poised to win from massive structural change.

Read More
November 16, 2023

Hedge Fund Veteran Talks Lowest Moment In Toscafund’s 23-Year Run

Most hedge fund managers brag about their wins and shy away from their losses – Martin Hughes is not most hedge fund managers.

Read More
November 16, 2023

The ‘Armageddon Scenario’ Worrying The Future Fund CIO

Mr Samild shared his thoughts on the bond market – which underpins the returns of other assets – ahead of his appearance at Friday’s Sohn Hearts & Minds charity conference at the Sydney Opera House.

Read More
Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.
November 15, 2023

Advancing Medicine Is In Daniel MacArthur’s DNA

When genomic scientist Daniel MacArthur had the opportunity to set up a new Centre for Population Genomics in Australia in 2019, he jumped at the chance to return home after 12 years living overseas.

Read More
November 15, 2023

Ashish Swarup - Invest In Snacks, Let's Get That Bread | Aikya Investment Management

Ashish Swarup, Portfolio Manager and Investment Analyst of Aikya Investment Management joins Bryce and Ren to discuss emerging markets, and two stock deep dives.

Read More
November 15, 2023

Daniel Loeb’s Wall St Hedge Fund Third Point Raises Bets On Corporate Credit Crunch

An “obsession” around balance sheet strength and debt is creating a new wave of investment bets for the influential Wall Street hedge fund run by Daniel Loeb.

Read More
November 13, 2023

Bond Bullish On Commodity Stocks, Uranium

Mining stocks are poised to rise amid tight supply for key commodities such as copper, nickel and uranium, says Terra Capital founder Jeremy Bond.

Read More
November 13, 2023

This Hedge Fund Manager Is Making A 100-Year Bet On Luxury

European leisure and luxury – a designer handbag, a last-minute flight to Monte Carlo, a stay in a five-star hotel – is where many choose to spend their hard-earned cash. For Sharif el Khazen, it’s where he makes it.

Read More
November 12, 2023

How Munro Will Pick Its Next Stock Winner

Munro partner and portfolio manager Kieran Moore must select a single company to pitch to an audience of industry heavyweights at the prestigious Sohn Hearts & Minds conference in Sydney.

Read More
November 12, 2023

The Australian At The Centre Of Dalio’s Bridgewater – Who Loves It

The culture at Ray Dalio’s massive hedge fund has been a source of intrigue, and with a new book, controversy. Atul Lele says it’s made him a better investor.

Read More
November 10, 2023

Meet The Goldman Sachs Legend Shaking Up Venture Capital

Sheila Patel says it was time for the venture capital sector to “grow up” and higher rates will help do that job. VC firms need to think differently about how they invest.

Read More
November 8, 2023

Tom Naughton - There's Money In Mi Goreng | Prusik Investment

Tom Naughton is Managing Partner and CIO at Prusik Investment. In this episode, he chats to Equity Mates ahead of his appearance at the 2023 Sohn Hearts and Minds Conference.

Read More
November 6, 2023

Why Chris Kourtis just bought CSL and ResMed

A true contrarian investor, Chris Kourtis can find himself sounding a lot like a bull when in the company of bears, and there’s a lot to be bearish about at the moment.

Read More